December 16, 2008 – Researchers from Yale University School of Medicine compared narrow-band imaging (NBI) without high magnification to standard white light colonoscopy in differentiating colorectal polyps during real-time colonoscopy and found that NBI was not more accurate than white light colonoscopy.

The study found, however, a significant learning curve for these experienced endoscopists using NBI as a new diagnostic tool. Once this learning curve was achieved, NBI performed significantly better. The study appears in the December issue of “GIE: Gastrointestinal Endoscopy,” the monthly peer-reviewed scientific journal of the American Society for Gastrointestinal Endoscopy (ASGE).

Endoscopy is a procedure that uses an endoscope — a thin, flexible tube with a light and a lens on the end to look into the esophagus, stomach, duodenum, small intestine, colon, or rectum, in order to diagnose or treat a condition. Colonoscopy is frequently used to screen for colorectal cancer, which most typically develops from polyps. The two main polyp types are adenomatous, which are precancerous and hence require removal, and nonadenomatous, which do not have a high likelihood of developing into cancer.

Narrow-band imaging is a new optical technology that modifies white light by using only certain wavelengths to enhance the image. The technology provides more visual detail of the lining of the colon (including polyps) and of the small blood vessels near the surface of the polyps. At the present time, there is no widely adopted, easily applied method for distinguishing between adenomatous and nonadenomatous polyps during real-time colonoscopy. From a practical standpoint, the ability to distinguish the two would allow the endoscopist to remove only those polyps with precancerous potential.

“In this prospective trial, we aimed to compare standard broadband white light colonoscopy with narrow-band imaging for the differentiation of colorectal polyps during real-time colonoscopy by using a modified Kudo pit pattern classification and vascular color intensity grading,” said study lead author Jason Rogart, M.D., Yale University School of Medicine, New Haven, CT. “Overall, NBI accuracy was 80 percent, compared with 77 percent for white light alone. We also demonstrated that improved performance can be achieved over time. NBI was most useful in correctly identifying adenomas, polyps that have the most risk of developing into cancer, especially those that are small.”

The authors said, to their knowledge, this is the largest study to date that addresses the question of whether NBI outperforms ordinary white light in predicting the histopathologic diagnosis of polyps during real-time colonoscopy.

For more information: www.asge.org


Related Content

News | ACR

February 6, 2024 — An update to the CT Colonography Reporting and Data System (C-RADS) has been published Jan. 30 in the ...

Time February 06, 2024
arrow
News | Colonoscopy Systems

A team of Johns Hopkins data researchers is studying the economic and safety implications associated with the devices used to perform colonoscopies as a disposable version inches closer to widespread availability.

Time August 26, 2019
arrow
News | Colonoscopy Systems

A new study finds that trends in colonoscopy rates did not fully align with the increase in colorectal cancer (CRC) in younger adults, adding to evidence that the rise in early onset CRC is not solely a result of more detection. The study is published early online in the Journal of Medical Screening.

Time August 06, 2019
arrow
News | Colonoscopy Systems

Check-Cap Ltd. has initiated its U.S. pilot study of the C-Scan system for prevention of colorectal cancer through detection of precancerous polyps, following Institutional Review Board (IRB) approval and full Investigational Device Exemption (IDE) application approval by the U.S. Food and Drug Administration (FDA). The first patients have ingested C-Scan, a preparation-free capsule, at the New York University School of Medicine.

Time April 15, 2019
arrow
News | Colonoscopy Systems

https://www.congress.gov/bill/115th-congress/house-bill/1298?q=%7B%22se… cancer care advocacy groups and medical societies are calling on Congress to pass the CT Colonography Screening for Colorectal Cancer Act (S.3465/HR 1298). The bipartisan bill introduced in the U.S. Senate September 19 would provide Medicare coverage for screening computed tomography colonography (CTC), commonly known as virtual colonoscopy.

Time September 27, 2018
arrow
News | Colonoscopy Systems

Check-Cap Ltd. announced the interim results for its post-CE approval study of the C-Scan system Version 3, an ingestible, capsule-based device for preparation-free colorectal cancer (CRC) screening. The company said data from the multicenter clinical investigation showed promising results for detecting patients with polyps in an un-prepped colon.

Time September 04, 2018
arrow
News | Colonoscopy Systems

An updated American Cancer Society guideline says colorectal cancer screening should begin at age 45 for people at average risk. The recommendation is based in part on data showing rates of colorectal cancer are increasing in young and middle-aged populations.

Time May 30, 2018
arrow
News | Colonoscopy Systems

February 8, 2018 – The U.S. Food and Drug Administration (FDA) announced on February 7, 2018, that Pentax Medical’s ...

Time February 08, 2018
arrow
News | Colonoscopy Systems

August 31, 2017 — A fast, simple blood test for ulcerative colitis using infrared spectroscopy could provide a cheaper ...

Time August 31, 2017
arrow
News | Colonoscopy Systems

People with insurance policies that cover computed tomography (CT) colonography for colorectal cancer screening are almost 50 percent more likely to get screened than those whose policies don’t cover the procedure, according to a new study appearing online in the journal Radiology.

Time July 12, 2017
arrow
Subscribe Now